VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
WVE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
WVEWave Life Sciences Ltd.
$3.78$727M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksWVEQuarterly Financials

Wave Life Sciences Ltd. (WVE) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Wave Life Sciences Ltd. (WVE) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

WVE Income Statement

Quarterly statement

WVE Income Statement

Wave Life Sciences Ltd. (WVE) annual income statement — 13-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue2.27M38.25M17.25M7.61M8.7M9.18M83.75M-7.68M19.69M12.54M29.06M49.21M22.11M12.93M1.24M285K375K1.75M1.76M36.42M
Revenue Growth %-73.88%316.85%-79.41%199.11%-55.82%-26.82%188.23%-115.6%-10.92%-3.02%2245.12%17168.07%5794.93%638.8%-29.8%-99.22%-86.49%--81.3%955.74%
Cost of Goods Sold002.26M02.2M2.16M00002.18M31.64M33.31M30.98M31.08M27.57M29.73M27.47M25.76M31.09M
COGS % of Revenue--13.12%-25.24%23.59%----7.51%64.29%150.7%239.61%2508.31%9675.44%7928.8%1569.71%1459.55%85.35%
Gross Profit2.27M38.25M14.98M7.61M6.5M7.01M83.75M-7.68M19.69M12.54M26.87M17.57M-11.21M-18.05M-29.84M-27.29M-29.36M-25.72M-24M5.34M
Gross Margin %100%100%86.88%100%74.76%76.41%100%100%100%100%92.49%35.71%-50.7%-139.61%-2408.31%-9575.44%-7828.8%-1469.71%-1359.55%14.65%
Gross Profit Growth %-65.06%445.51%-82.11%199.11%-66.98%-44.08%211.63%-143.68%275.7%169.46%190.06%164.39%61.82%29.82%-24.35%-611.34%-1.73%--16.52%121.5%
Operating Expenses76.07M69.54M71.45M63.96M59.26M56.81M60.78M56.24M54.69M47M45.56M13.13M12.27M12.23M13.72M11.61M12.81M12.37M12.11M12.94M
OpEx % of Revenue3348.28%181.83%414.32%840.71%681.25%619.24%72.58%-732.66%277.72%374.83%156.79%26.68%55.48%94.63%1107.67%4073.33%3414.93%707.09%686.35%35.54%
Selling, General & Admin24.78M22.1M20.9M18.09M17.99M18.36M16.14M15.04M14.3M13.55M13.66M13.13M12.27M12.23M13.72M11.61M12.81M12.37M12.11M12.94M
SG&A % of Revenue1090.67%57.79%121.18%237.74%206.79%200.08%19.27%-195.96%72.6%108.06%47.03%26.68%55.48%94.63%1107.67%4073.33%3414.93%707.09%686.35%35.54%
Research & Development51.29M47.44M52.81M45.87M43.47M40.62M44.65M41.2M40.39M33.45M34.07M31.64M33.31M30.98M31.08M27.57M29.73M27.47M25.76M31.09M
R&D % of Revenue2257.61%124.04%306.26%602.97%499.7%442.75%53.31%-536.7%205.12%266.76%117.27%64.29%150.7%239.61%2508.31%9675.44%7928.8%1569.71%1459.55%85.35%
Other Operating Expenses00-1000K0-1000K-1000K0000-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K
Operating Income-73.8M-31.3M-56.47M-56.35M-52.76M-49.8M22.97M-63.91M-35M-34.46M-18.68M4.44M-23.47M-30.29M-43.56M-38.9M-42.16M-38.09M-36.11M-7.61M
Operating Margin %-3248.28%-81.83%-327.44%-740.71%-606.5%-542.82%27.42%832.66%-177.72%-274.83%-64.3%9.03%-106.18%-234.24%-3515.98%-13648.77%-11243.73%-2176.8%-2045.89%-20.89%
Operating Income Growth %-39.88%37.16%-345.86%11.83%-50.75%-44.54%222.94%-1538.23%-49.09%-13.78%57.12%111.42%44.33%20.5%-20.64%-411.36%-5.87%12.37%-19.12%77.9%
EBITDA-71.5M-28.99M-54.2M-54.12M-50.56M-47.64M25.12M-61.76M-32.83M-32.28M-16.5M5.64M-22.18M-28.85M-42.05M-37.26M-40.47M-36.36M-34.33M-5.76M
EBITDA Margin %-3146.83%-75.81%-314.32%-711.4%-581.25%-519.24%30%804.55%-166.69%-257.47%-56.79%11.46%-100.35%-223.16%-3393.95%-13074.39%-10791.73%-2077.94%-1945.1%-15.81%
EBITDA Growth %-41.4%39.14%-315.76%12.36%-54.04%-47.58%252.26%-1194.79%-47.97%-11.88%60.76%115.14%45.18%20.66%-22.49%-546.91%-6.72%11.33%-21.33%82.21%
D&A (Non-Cash Add-back)2.31M2.31M2.26M2.23M2.2M2.16M2.16M2.16M2.17M2.18M2.18M1.2M1.29M1.43M1.51M1.64M1.7M1.73M1.78M1.85M
EBIT-73.53M-26.09M-53.18M-53.85M-50.47M-46.88M29.25M-61.78M-32.92M-31.56M-18.68M4.44M-23.47M-30.29M-43.56M-38.9M-42.16M-38.09M-36.11M-7.61M
Net Interest Income4.72M5.29M3.05M2.18M2.37M2.88M3.74M1.8M2.09M2.54M1.84M1.96M2.25M00491K0000
Interest Income4.72M5.29M3.05M2.18M2.37M2.88M3.74M1.8M2.09M2.54M1.84M1.96M2.25M00596K0000
Interest Expense00000000000--00105K0000
Other Income/Expense4.45M5.21M3.29M2.5M2.29M2.93M6.29M2.13M2.07M2.9M2.43M3.48M2.37M2.88M535K-105K868K280K1.53M1.38M
Pretax Income-69.36M-26.09M-53.18M-53.85M-50.47M-46.88M29.25M-61.78M-32.92M-31.56M-16.26M7.93M-21.1M-27.41M-43.03M-39M-41.3M-37.81M-34.58M-6.23M
Pretax Margin %-3052.6%-68.21%-308.37%-707.83%-580.17%-510.93%34.93%804.85%-167.19%-251.7%-55.95%16.11%-95.47%-211.97%-3472.8%-13685.61%-11012.27%-2160.8%-1959.26%-17.1%
Income Tax00000000000677K00681K000204K0
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%8.54%0%0%-1.58%0%0%0%-0.59%0%
Net Income-69.36M-26.09M-53.18M-53.85M-50.47M-46.88M29.25M-61.78M-32.92M-31.56M-16.26M7.25M-21.1M-27.41M-43.71M-39M-41.3M-37.81M-34.78M-6.23M
Net Margin %-3052.6%-68.21%-308.37%-707.83%-580.17%-510.93%34.93%804.85%-167.19%-251.7%-55.95%14.74%-95.47%-211.97%-3527.76%-13685.61%-11012.27%-2160.8%-1970.82%-17.1%
Net Income Growth %-37.42%44.35%-281.79%12.83%-53.29%-48.55%279.95%-951.9%-56%-15.15%62.81%118.59%48.9%27.53%-25.65%-526.07%-6.53%10.95%-20.83%81.18%
Net Income (Continuing)-69.36M-26.09M-53.18M-53.85M-50.47M-46.88M29.25M-61.78M-32.92M-31.56M-16.26M7.25M-21.1M-27.41M-43.71M-39M-41.3M-37.81M-34.78M-6.23M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.34-0.13-0.30-0.32-0.31-0.290.17-0.47-0.25-0.24-0.150.07-0.20-0.24-0.47-0.420.00-0.62-0.61-0.12
EPS Growth %-9.68%55.17%-276.47%31.91%-24%-20.83%213.33%-818.65%-25%0%68.09%115.57%-61.29%22.95%-250%100.24%27.91%-3.39%86.05%
EPS (Basic)-0.34-0.13-0.30-0.32-0.31-0.290.18-0.47-0.25-0.24-0.150.07-0.20-0.24-0.47-0.420.00-0.62-0.61-0.12
Diluted Shares Outstanding202.1M200.17M180.15M167.74M163.99M162.53M172.29M132.56M129.53M129.27M109.63M106.98M105.46M102.06M93.99M93.9M66.48M60.52M57.19M50.71M
Basic Shares Outstanding202.1M200.17M180.15M167.74M163.99M162.53M161.49M131.45M129.53M129.27M109.63M106.03M105.46M102.06M93.99M92.87M66.48M60.52M57.01M50.71M
Dividend Payout Ratio--------------------